Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
Abstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultane...
Saved in:
| Main Authors: | Shungo Yano, Taiju Miyagami, Takayuki Furusaka, Nagamasa Kano, Toshio Naito |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-03-01
|
| Series: | Clinical Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ccr3.7001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico
by: Jesús Arturo Ruiz-Quiñones, et al.
Published: (2022-09-01) -
Steroid-sparing benefits of biologic use in hypereosinophilic syndrome and substantial disease burden across subtypes
by: Jeremiah Hwee, et al.
Published: (2025-05-01) -
False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19
by: Jeel Moya-Salazar, et al.
Published: (2025-08-01) -
Acute lymphoblastic leukemia with eosinophilia: diagnostic and treatment features
by: O. D. Gurieva, et al.
Published: (2025-05-01) -
CHARACTERIZATION OF CONSULTATIONS REQUESTED FOR PATIENTS WITH ELEVATED BLOOD EOSINOPHILS: A TERTIARY IMMUNOLOGY AND ALLERGY CLINIC EXPERIENCE
by: Şengül Beyaz, et al.
Published: (2022-07-01)